Purity >95%, by SDS-PAGE with silver staining. MW (observed): 67-81 kDa, reducing conditions. MW (theoretical): 49 kDa. The Recombinant Human LRIT2 Protein from R&D Systems is derived from CHO. The Recombinant Human LRIT2 Protein has been validated for the following applications: Bioactivity.
Size
50 ug
Concentration
n/a
Applications
Bioactivity
Other Names
immunoglobulin-like domain and transmembrane domain-containing protein 2, leucine rich repeat containing 22, leucine-rich repeat, immunoglobulin-like and transmembrane domains 2, leucine-rich repeat-containing protein 22, LRRC22, PAL2